BEYOND CHEMOTHERAPY: THE MISSING LINK IN WOMEN-CENTERED CANCER CARE

Psychosocial support can transform cancer treatment outcomes, yet it remains one of the most  overlooked components of care for women. 

During a panel marking World Cancer Day- February 2026, the room fell silent as survivors  shared stories no statistic could capture. One woman admitted she initially ran away from  chemotherapy because fear felt stronger than hope. Another described living with cancer for ten  years, enduring multiple surgeries, yet standing before the audience with a walking stick and  quiet determination. Their message was clear: surviving cancer requires far more than medicine  alone. It requires emotional strength, family support, compassionate care, and a health system  that recognizes the patient beyond the disease. 

Across the world, healthcare systems increasingly promote patient-centered care, recognizing  that treatment must address not only physical illness but also the emotional and social realities  of patients. Yet in many low- and middle-income countries, cancer care still focuses largely on  clinical treatment while overlooking psychosocial needs. For many women, this gap can be as  devastating as the illness itself. 

Cancer rarely affects only the body. It disrupts identity, family stability, finances, and mental well being. A diagnosis often triggers fear, anxiety, stigma, and uncertainty about the future. Women,  who often serve as caregivers and emotional anchors within families, carry an especially heavy  

burden when faced with cancer. Concerns about motherhood, body image, family  responsibilities, and financial survival frequently unfold silently alongside the clinical battle. 

This is why psychosocial support must become an integral component of cancer care. 

Evidence shows that structured interventions such as counselling, peer support groups, and  patient navigation improve treatment adherence, quality of life, and overall outcomes. When  patients feel emotionally supported, they are more likely to remain engaged in treatment,  communicate openly with healthcare providers, and sustain the resilience needed to navigate  complex therapies. 

The experiences of survivors illustrate this clearly. 

Breast cancer survivor Kosi, a medical laboratory scientist and mother, detected a small lump  during self-examination and sought care immediately. Her scientific knowledge enabled early  diagnosis and treatment. Yet her greatest challenge was the emotional strain of spending  months away from her children during treatment. Family support sustained her, and today she  advocates for early detection and screening. 

Elizabeth, widely known as Dutchess Lizzy, faced a more difficult journey. After discovering a  lump following a miscarriage, her concerns were initially dismissed. When cancer was  confirmed, the diagnosis brought fear, financial pressure, and social expectations to pursue  alternative therapies. Support from her husband and community helped her continue treatment.  Today, she inspires thousands of women to seek early diagnosis and second opinions.

Similar courage emerged during the same panel discussion. Survivor Julian Omang initially fled  from chemotherapy after her ovarian cancer diagnosis but returned following encouragement  from her family, a decision that saved her life. Another survivor, Madam Dennis, has endured a  decade-long cancer journey involving multiple surgeries yet continues to advocate for patients’  dignity and rights. 

These stories reveal a powerful truth: survival is rarely achieved through medicine alone.  Emotional resilience, family support, and compassionate care systems are equally vital. 

Integrating psychosocial services into oncology care is therefore essential for genuine patient centered care. Hospitals must embed trained counsellors within oncology clinics, while survivor  networks and community health workers can provide emotional support and guidance through  complex treatment pathways. 

If governments and health institutions are serious about equitable cancer care, psychosocial  support must be integrated into national cancer control plans, oncology training programmes,  and routine treatment pathways. 

Psychosocial support is not an optional add-on to cancer care. It is the bridge between  treatment and healing.